| (USD) | Sep 2025 | Y/Y change |
|---|---|---|
| Revenue | 19.07M | — |
| Operating expense | — | — |
| Net income | -16.29M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, XLO returned -6.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +3.0% |
| 1 year | -6.2% |
| All-time high | $235.06 (Oct 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in XLO would be worth today ›No. Xilio Therapeutics, Inc. has not paid a dividend in the past 12 months.
Xilio Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol XLO.
Xilio Therapeutics, Inc. is part of the Healthcare sector.
Xilio Therapeutics, Inc. has a market cap of 60.73M USD, based on the latest quote.
